Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

WCLC 2026: Lung cancer research highlights

Dr Luis Raez - Memorial Cancer Institute, Miami, USA
WCLC 2026: Lung cancer research highlights ( Dr Luis Raez - Memorial Cancer Institute, Miami, USA )
14 Oct 2026

Izalontamab brenitecan shows promising activity in previously treated EGFR mutated NSCLC

Dr Alex Spira - Virginia Cancer Specialists Research Institute, Fairfax, USA
Izalontamab brenitecan shows promising activity in previously treated EGFR mutated NSCLC ( Dr Alex Spira - Virginia Cancer Specialists Research Institute, Fairfax, USA )
13 Oct 2026

Multilevel factors shaping blinatumomab delivery across diverse LMICs

Dr Caitlyn Duffy - St. Jude Children’s Research Hospital, Memphis, USA
Multilevel factors shaping blinatumomab delivery across diverse LMICs ( Dr Caitlyn Duffy - St. Jude Children’s Research Hospital, Memphis, USA )
12 Oct 2026

Building the cancer system of the future in UAE

Dr Stephen Grobmyer - Cleveland Clinic Abu Dhabi - Fatima bint Mubarak Center, Abu Dhabi, United Arab Emirates
Building the cancer system of the future in UAE ( Dr Stephen Grobmyer - Cleveland Clinic Abu Dhabi - Fatima bint Mubarak Center, Abu Dhabi, United Arab Emirates )
9 Oct 2026

Zidesamtinib shows promising efficacy in TKI-naïve ROS1-positive advanced NSCLC

Dr Alexander Drilon - Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center, New York, USA
Zidesamtinib shows promising efficacy in TKI-naïve ROS1-positive advanced NSCLC ( Dr Alexander Drilon - Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center, New York, USA )
8 Oct 2026

Isa-VRd shows sustained benefit in transplant-ineligible newly diagnosed multiple myeloma

Prof Xavier Leleu - Poitiers University Hospital, Poitiers, France
Isa-VRd shows sustained benefit in transplant-ineligible newly diagnosed multiple myeloma ( Prof Xavier Leleu - Poitiers University Hospital, Poitiers, France )
7 Oct 2026

Pembrolizumab plus chemotherapy shows pathological responses in resectable pleural mesothelioma

Dr Giulia Pasello - University of Padua, Padua, Italy
Pembrolizumab plus chemotherapy shows pathological responses in resectable pleural mesothelioma ( Dr Giulia Pasello - University of Padua, Padua, Italy )
6 Oct 2026

Adjuvant osimertinib delivers sustained long term survival benefit in EGFR mutated NSCLC

Dr Roy Herbst - Dartmouth Cancer Center, Lebanon, USA
Adjuvant osimertinib delivers sustained long term survival benefit in EGFR mutated NSCLC ( Dr Roy Herbst - Dartmouth Cancer Center, Lebanon, USA )
28 Sep 2026

Cemiplimab shows strong survival benefit in KRAS G12C positive advanced NSCLC

Prof David Gandara - University of California Davis Comprehensive Cancer Center, Sacramento, USA
Cemiplimab shows strong survival benefit in KRAS G12C positive advanced NSCLC ( Prof David Gandara - University of California Davis Comprehensive Cancer Center, Sacramento, USA )
28 Sep 2026

Amivantamab plus chemotherapy extends overall survival in EGFR exon 20 insertion NSCLC

Dr Chul Kim - Georgetown Cancer Institute, Washington, USA
Amivantamab plus chemotherapy extends overall survival in EGFR exon 20 insertion NSCLC ( Dr Chul Kim - Georgetown Cancer Institute, Washington, USA )
28 Sep 2026

Biomarker guided PARP inhibitor maintenance improves outcomes in ovarian cancer meta analysis of phase 3 trials

Dr Aakash Pandit - Chitwan Medical College Teaching Hospital, Bharatpur, Nepal
Biomarker guided PARP inhibitor maintenance improves outcomes in ovarian cancer meta analysis of phase 3 trials ( Dr Aakash Pandit - Chitwan Medical College Teaching Hospital, Bharatpur, Nepal )
19 Sep 2026

Prolgolimab plus chemotherapy improves long term survival in advanced nonsquamous NSCLC

Dr Fedor Moiseenko - N.P. Napalkov City Cancer Center, Saint Petersburg, Russian Federation
Prolgolimab plus chemotherapy improves long term survival in advanced nonsquamous NSCLC ( Dr Fedor Moiseenko - N.P. Napalkov City Cancer Center, Saint Petersburg, Russian Federation )
18 Sep 2026